| Entry |
|
|---|
| Name |
Nicotine;
(S)-3-(1-Methylpyrrolidin-2-yl)pyridine;
(S)-Nicotine;
3-[(S)-1-Methylpyrrolidin-2-yl]pyridine
|
|---|
| Formula |
C10H14N2
|
|---|
| Exact mass |
162.1157
|
|---|
| Mol weight |
162.23
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00760 | Nicotinate and nicotinamide metabolism |
| map00960 | Tropane, piperidine and pyridine alkaloid biosynthesis |
| map00980 | Metabolism of xenobiotics by cytochrome P450 |
| map01064 | Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid |
| map01110 | Biosynthesis of secondary metabolites |
| map01120 | Microbial metabolism in diverse environments |
| map05207 | Chemical carcinogenesis - receptor activation |
|
|---|
| Module |
| M00810 | Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde |
|
|---|
| Network |
|
|---|
| Enzyme |
|
|---|
| Brite |
Phytochemical compounds [BR:br08003]
Alkaloids
Alkaloids derived from nicotinic acid
Pyridine alkaloids
C00745 Nicotine
Pesticides [BR:br08007]
Pesticides
Insecticides
Others
C00745 Nicotine
Natural toxins [BR:br08009]
Phytotoxins
Alkaloids
Others
C00745 Nicotine
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07B DRUGS USED IN ADDICTIVE DISORDERS
N07BA Drugs used in nicotine dependence
N07BA01 Nicotine
D03365 Nicotine (USP) <JP/US>
USP drug classification [BR:br08302]
Anti-Addiction/Substance Abuse Treatment Agents
Smoking Cessation Agents
Nicotine
D03365 Nicotine (USP)
Therapeutic category of drugs in Japan [BR:br08301]
7 Agents not mainly for therapeutic purpose
79 Other agents not mainly for therapeutic purpose
799 Miscellaneous
7990 Miscellaneous
D03365 Nicotine (USP)
Classification of Japanese OTC drugs [BR:br08313]
Stop smoking aid
77 Stop smoking aid
D03365 Nicotine (USP)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Nicotine
D03365 Nicotine (USP)
Designated second-class OTC drugs
Inorganic and organic chemicals
Nicotine
D03365 Nicotine (USP)
Second-class OTC drugs
Inorganic and organic chemicals
Nicotine
D03365 Nicotine (USP)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01638 CYP2A6 substrate
DG00994 Nicotine
D03365 Nicotine
Metabolizing enzyme inducer
DG01637 CYP1A2 inducer
DG00994 Nicotine
D03365 Nicotine
Unclassified
DG01715 Drugs for nicotine dependence
DG00994 Nicotine
D03365 Nicotine
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Acetylcholine (nicotinic)
CHRN
D03365 Nicotine (USP) <JP/US>
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D03365
Rx-to-OTC switch list in the USA [br08315.html]
D03365
Rx-to-OTC switch list in Japan [br08314.html]
D03365
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 12
1 C8x C 29.1900 -17.5700
2 C8x C 29.1900 -18.9700
3 N5x N 30.3800 -19.6700
4 C8x C 31.6400 -18.9700
5 C8y C 31.6400 -17.5700
6 C8x C 30.3800 -16.8700
7 C1y C 32.8300 -16.8700
8 C1x C 34.1600 -17.2200
9 C1x C 35.0000 -16.1000
10 C1x C 34.0900 -14.9800
11 N1y N 32.8300 -15.4700
12 C1a C 31.6400 -14.7000
BOND 13
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 5 1 #Up
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 7 11 1
13 11 12 1
|
|---|
